HKSE - Delayed Quote HKD

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)

7.870

+0.300

+(3.96%)

At close: January 28 at 11:40:20 AM GMT+8

IDEAYA Announces Development Candidate Nomination of IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise with Biocytogen

IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced the selection of IDE034, a potential first-in-class B7H3/PTK7 topo-I-payload BsADC, as a development candidate and the exercise of its option for an exclusive worldwide license from Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315) for potential first-in-class B7H3/PTK7 BsADC program.

PR Newswire 2 months ago

2315.HK
+3.96%
IDYA
Exploring High Growth Tech Stocks In Hong Kong

As global markets experience shifts with interest rate adjustments and economic indicators showing mixed signals, the Hong Kong market remains a focal point for investors seeking opportunities in high-growth tech sectors. In this dynamic environment, identifying promising stocks often involves assessing companies that not only demonstrate robust innovation and adaptability but also align well with prevailing market trends and economic conditions.

Simply Wall St. 3 months ago

9966.HK

XDNCF

2315.HK
+3.96%
Top SEHK Growth Companies With High Insider Ownership In October 2024

As global markets experience varied economic shifts, with U.S. stocks reaching new highs and Chinese equities facing declines, the Hong Kong market remains a focal point for investors seeking growth opportunities amidst these fluctuations. In this context, identifying companies with high insider ownership can be particularly insightful, as such alignment often signals confidence in a company's potential to navigate current economic conditions effectively.

Simply Wall St. 3 months ago

2598.HK

ESRCF

2315.HK
+3.96%
High Growth Tech Stocks To Watch In Hong Kong This September 2024

As global markets show signs of recovery with technology stocks leading the charge, Hong Kong's tech sector remains a focal point for investors seeking high growth opportunities. Amidst this dynamic landscape, identifying promising tech stocks involves evaluating their innovation potential, market position, and resilience to economic fluctuations.

Simply Wall St. 4 months ago

3393.HK

2315.HK
+3.96%
9966.HK
Top 3 SEHK Growth Companies With High Insider Ownership In September 2024

As global markets face economic uncertainties, the Hong Kong market has not been immune to these fluctuations, with the Hang Seng Index recently experiencing a notable decline. Despite this backdrop, growth companies with high insider ownership often present unique opportunities for investors due to their potential for strong alignment between management and shareholder interests.

Simply Wall St. 4 months ago

KSHTY

KUASF

MPNGF
Top 3 High Growth Tech Stocks In Hong Kong To Watch

As global markets show signs of optimism, with the Hang Seng Index up 1.99% and technology stocks leading gains, Hong Kong's tech sector is drawing significant investor attention. In this dynamic environment, identifying high-growth tech stocks requires a keen eye on companies that are not only innovating but also demonstrating strong fundamentals and market adaptability.

Simply Wall St. 5 months ago

2315.HK
+3.96%
9966.HK

3393.HK
SEHK's Top Growth Companies With High Insider Ownership For August 2024

The Hong Kong market has shown resilience amid global economic uncertainties, with the Hang Seng Index gaining 0.85% recently. As investors navigate these volatile conditions, companies with high insider ownership often signal strong confidence from those closest to the business. In this article, we explore three growth companies listed on the SEHK that not only show promising potential but also have significant insider ownership, aligning interests between management and shareholders.

Simply Wall St. 5 months ago

2315.HK
+3.96%
KSHTY

KUASF
IDEAYA Biosciences Announces Option and License Agreement for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program with Biocytogen

IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced that it has entered into an option and license agreement for a potential first-in-class B7H3/PTK7 BsADC program with Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody/ADC therapeutics.

PR Newswire 5 months ago

IDYA

2315.HK
+3.96%
SEHK Growth Companies With High Insider Ownership In July 2024

As global markets experience fluctuations, the Hong Kong stock market remains a focal point for investors looking for growth opportunities. In this context, companies with high insider ownership can be particularly intriguing, as they often signal strong confidence from those closest to the business in its future prospects.

Simply Wall St. 6 months ago

2315.HK
+3.96%
MPNGF

MPNGY
Biocytogen Awarded U.S. Patent for RenLite® Common Light Chain Mouse Platform

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) announced United States Patent and Trademark Office (USPTO) patent grant for independently developed RenLite® fully human common light chain mouse platform.

PR Newswire 7 months ago

2315.HK
+3.96%
SEHK Growth Companies With High Insider Ownership Showcasing Promising Futures

Amidst a landscape of fluctuating global markets, the Hong Kong stock market continues to present unique opportunities for discerning investors. This article explores three growth-oriented companies in the SEHK with high insider ownership, a trait often associated with strong confidence in a company's future prospects and alignment of interests between shareholders and management.

Simply Wall St. 7 months ago

2373.HK
+1.94%
2315.HK
+3.96%
6639.HK
Exploring Three SEHK Growth Companies With High Insider Ownership

Amidst a backdrop of fluctuating global markets, Hong Kong's Hang Seng Index recently showcased a robust gain of 3.11%, signaling a positive sentiment in the region. This uptick provides an intriguing context for examining growth companies with high insider ownership on the SEHK, as such firms often benefit from aligned interests between shareholders and management, potentially enhancing stability and confidence in challenging economic climates.

Simply Wall St. 8 months ago

2373.HK
+1.94%
6639.HK

2315.HK
+3.96%

Performance Overview

Return	2315.HK	HANG SENG INDEX
YTD	-6.31%	+0.92%
1-Year	-18.19%	+26.79%
3-Year	-70.08%	-15.05%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)

IDEAYA Announces Development Candidate Nomination of IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise with Biocytogen

Exploring High Growth Tech Stocks In Hong Kong

Top SEHK Growth Companies With High Insider Ownership In October 2024

High Growth Tech Stocks To Watch In Hong Kong This September 2024

Top 3 SEHK Growth Companies With High Insider Ownership In September 2024

Top 3 High Growth Tech Stocks In Hong Kong To Watch

SEHK's Top Growth Companies With High Insider Ownership For August 2024

IDEAYA Biosciences Announces Option and License Agreement for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program with Biocytogen

SEHK Growth Companies With High Insider Ownership In July 2024

Biocytogen Awarded U.S. Patent for RenLite® Common Light Chain Mouse Platform

SEHK Growth Companies With High Insider Ownership Showcasing Promising Futures

Exploring Three SEHK Growth Companies With High Insider Ownership

Performance Overview